Forgent Power Surges 37% Above Follow-On Price as AI Data Center Demand Drives Record Orders
IPO Michael Okonkwo

Forgent Power Surges 37% Above Follow-On Price as AI Data Center Demand Drives Record Orders

Forgent Power shares surged 37% above its $47 follow-on price, fueled by record bookings and backlog as AI data center demand keeps investor interest high.

ETN VRT NVT
Palantir Shares Slip Despite New Google Cloud Deal and Commercial Wins
Technology Sarah Chen

Palantir Shares Slip Despite New Google Cloud Deal and Commercial Wins

Palantir shares declined 0.9% to $140.89, reversing early gains, as investors weigh the impact of new Google Cloud and commercial deals against ongoing valuation sensitivity and regulatory risks.

PLTR
Grab Holdings Rises as Nasdaq Slips; Fintech Growth in Focus
Markets Daniel Marsh

Grab Holdings Rises as Nasdaq Slips; Fintech Growth in Focus

Grab Holdings shares rose 2.9% on Thursday, bouncing from prior losses, as the market evaluates its Q1 results and fintech expansion amid sector headwinds.

GRAB UBER LYFT
Goldman Sachs Surge Lifts Dow to Record High Amid Financial Sector Rotation
Markets Daniel Marsh

Goldman Sachs Surge Lifts Dow to Record High Amid Financial Sector Rotation

Goldman Sachs shares surged 4.6% to $1,095.89, pushing the Dow to a record high as financial stocks rallied. The bank's lead underwriting of SpaceX's $75B IPO and solid Q1 results boosted sentiment.

GS JPM MS SPY QQQ XLF
Celsius Shares Slide on Texas Probe Into Alani Nu Marketing
Regulation James Calloway

Celsius Shares Slide on Texas Probe Into Alani Nu Marketing

Celsius shares dropped 6.8% after Texas opened a probe into whether Alani Nu drinks misled consumers about safety for minors, threatening growth plans.

CELH PEP MNST
Veru Stock Surges on Novo Nordisk Obesity Trial Collaboration
Markets Daniel Marsh

Veru Stock Surges on Novo Nordisk Obesity Trial Collaboration

Veru shares surged 112% to $4.78 after Novo Nordisk will provide Wegovy for Veru's Phase 2b obesity trial. Analysts kept $24-$25 targets, but Veru warned of trial risks and reimbursement challenges.

VERU NVO
CRISPR Therapeutics Surges 12% on Gene-Editing Sector Rally
Markets Daniel Marsh

CRISPR Therapeutics Surges 12% on Gene-Editing Sector Rally

CRISPR Therapeutics shares surged 12% in New York trading, buoyed by a sector-wide gene-editing rally and Eli Lilly's $1.9 billion deal with Ascidian Therapeutics.

CRSP LLY NTLA BEAM EDIT XBI
Reddit Rallies on Ad Tool Upgrades and Analyst Endorsement
Technology Sarah Chen

Reddit Rallies on Ad Tool Upgrades and Analyst Endorsement

Reddit shares jumped 6.3% on Thursday after Loop Capital reiterated a Buy rating and investors reacted to new automated app-ad tools.

RDDT META SNAP
Keel Infrastructure Tumbles as AI Data Center Hopes Face Permitting Hurdles
Markets Daniel Marsh

Keel Infrastructure Tumbles as AI Data Center Hopes Face Permitting Hurdles

Keel shares slipped 1.7% after a 98% monthly surge, as the market focuses on whether the company can convert its power-rich sites into AI data center leases amid Q1 losses.

APLD
Consumers Energy Seeks $456M Annual Rate Hike, Citing Grid Upgrades
Regulation James Calloway

Consumers Energy Seeks $456M Annual Rate Hike, Citing Grid Upgrades

Consumers Energy has filed for a $456 million annual rate hike that could boost residential bills by 9.8%, drawing criticism from Michigan's attorney general and consumer advocates.

DTE
AT&T Stock Slides on SpaceX Starlink Threat and Regulatory Setback
Markets Daniel Marsh

AT&T Stock Slides on SpaceX Starlink Threat and Regulatory Setback

AT&T shares fell 3.7% on Thursday after Oppenheimer downgraded the stock, warning that SpaceX's Starlink could disrupt the US communications market. The Supreme Court also upheld FCC fines against AT&T.

T TMUS VZ
Nu Holdings Rises on $1B Buyback but Analysts Stay Wary
Markets Daniel Marsh

Nu Holdings Rises on $1B Buyback but Analysts Stay Wary

Nu Holdings shares rose 4% on a $1 billion buyback announcement, but analysts remain cautious amid CFO change and credit concerns.

NU